N4773
Neuron-specific enolase from human brain
≥95% (SDS-PAGE), buffered aqueous solution
Synonym(s):
2-Phospho-D-glycerate hydro-lyase, Enolase, Neuron-specific from human brain, NSE, Thermolabile antigen A
Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| 10 μg | Please contact Customer Service for Availability | CZK 9,780.00 |
About This Item
Specific activity:
≥10 units/mg protein
Assay:
≥95% (SDS-PAGE)
Biological source:
human brain
CZK 9,780.00
Please contact Customer Service for Availability
biological source
human brain
Quality Level
assay
≥95% (SDS-PAGE)
form
buffered aqueous solution
specific activity
≥10 units/mg protein
UniProt accession no.
shipped in
dry ice
storage temp.
−20°C
Gene Information
human ... ENO2(2026)
General description
Neuron-specific enolase (NSE) is a neuronal form of the glycolytic enzyme enolase, which was first found in extracts of brain tissue.
Application
Neuron-specific enolase from human brain has been used in a study to assess human amniotic mesenchymal stem cells in the treatment of focal cerebral ischemia. It has also been used in a study to investigate sinonasal teratocarcinosarcoma with rhabdoid features. [1]
Biochem/physiol Actions
Neuron-specific enolase (NSE) is expressed in all neuronal cell types, and its expression marks the acquisition of synaptic function. Following acute neuronal injury, NSE levels are increased in neuronal cell bodies. Increased levels of NSE in serum and cerebrospinal fluid have been used as markers for injury and neuronal cell death. Tumors derived from many cell types, including most neuronal and neuroendocrine tumors, express NSE.
Neuron-specific enolase promotes survival of neurons and can provide neuroprotective effects by binding to neurons in a calcium-dependent manner. [2]
Physical form
Solution in 100 mM Tris-HCl, 5 mM MgSO4, 250 mM KCl, pH 5.0-5.2
Other Notes
One unit causes the formation of 1.0 μmole of phospho(enol)pyruvate per minute at pH 6.8 at 25 °C
1 of 1
This Item | |||
|---|---|---|---|
| biological source human brain | biological source human | biological source mouse | biological source mouse |
| assay ≥95% (SDS-PAGE) | assay ≥95% (SDS-PAGE) | assay - | assay - |
| specific activity ≥10 units/mg protein | specific activity - | specific activity - | specific activity - |
| Gene Information human ... ENO2(2026) | Gene Information human ... ENO2(2026) | Gene Information human ... ENO2(2026) | Gene Information human ... ENO2(2026) |
| form buffered aqueous solution | form liquid | form buffered aqueous solution | form buffered aqueous solution |
| shipped in dry ice | shipped in dry ice | shipped in dry ice | shipped in dry ice |
Storage Class
12 - Non Combustible Liquids
wgk
WGK 1
flash_point_f
Not applicable
flash_point_c
Not applicable
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Transplantation of human amniotic mesenchymal stem cells in the treatment of focal cerebral ischemia
Li, F., et al.
Molecular Medicine, 6, 625-630 (2012)
Jo-Heon Kim et al.
Pathology international, 61(12), 762-767 (2011-12-01)
Sinonasal teratocarcinosarcoma (SNTCS) is a very rare tumor developed in the nasal cavity and paranasal sinuses. The rhabdoid phenotype represents an aggressive biological behavior, but the rhabdoid feature has hitherto not been reported in cases of SNTCS. A 46-year-old man
Neuron-specific enolase is produced by neuroendocrine tumours
Tapia, F., et al.
Lancet, 317, 808-811 (1981)
Global Trade Item Number
| SKU | GTIN |
|---|---|
| N4773-10UG | 04061838071729 |